Elekta recently received FDA clearance for its Volumetric Modulated Arc Therapy (VMAT).
Reportedly empowering clinicians to treat more patients in significantly less time, Elekta VMAT offers the clinical efficacy of IMRT delivered in a fraction of the time, providing rapid treatment with daily 3D image guidance. Features of VMAT include faster treatment times, precise dose control, reduced radiation dose to healthy tissue and 3D Volumetric imaging.
Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...
August 09, 2024 
July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...
July 31, 2024 
News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...
July 30, 2024 
July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...
July 11, 2024 
July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...
July 09, 2024 
July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...
July 05, 2024 
July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...
July 03, 2024 
July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...
July 02, 2024 
June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...
June 03, 2024 
May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...
May 30, 2024